Targeting the right patients in treatment of severe eosinophilic asthma and bringing balance to their lives.

05 Dec 2022
Targeting the right patients in treatment of severe eosinophilic asthma and bringing balance to their lives.
In conjunction with World Asthma Day and launch ofmepolizumab, GSK organised a webinar for healthcare professionals titled “The Right Patients at the Right Time: Elevating Care for SEA Patients with Biologics". Associate Professor Dr Mariko Koh Siyue, Senior Consultant in Respiratory and Critical Care Medicine, briefed the audience on severe eosinophilic asthma and discussed two case studies.
Sponsored as an educational program by GlaxoSmithKline Pharmaceutical Sdn Bhd 

Resources

MY-GLA-332

MY-GLA-332

MY-GLA-332

MY-GLA-332